https://doi.org/10.4081/aiua.2022.2.217

Platelet volume parameters as a tool in the evaluation of acute ischemic priapism in patients with sickle cell anemia

Vol. 94 No. 2 (2022)
Submitted: May 31, 2022
Accepted: June 4, 2022
Published: June 30, 2022
Sickle cell anemia, Acute ischemic priapism, Platelet volume indices
Abstract Views: 768
PDF: 328
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Essa A. Adawi
dr.adawi@gmail.com
Department of Urology, Jazan University, KSA, Saudi Arabia.
Mazen A. Ghanem
Department of Urology, Jazan University, KSA, Saudi Arabia.

Objective: This study aimed to evaluate the predictive value of platelet volume indices (PVIs), such as mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT), as prognostic parameters of detumescence in acute ischemic priapism (IP) patients with sickle cell anemia (SCA) in steady-state who received intracavernosal injections of phenylephrine with aspiration and saline irrigation. Methods: Fifty-six SCA patients with acute IP and 54 healthy male control subjects were included in the research. Priapism was diagnosed by penile Doppler ultrasound and corporal blood gas tests before intervention. Measurements of PVIs (MPV, PDW, and PCT) and TLC were ordered for all participants. Additionally, the duration of priapism was recorded. The area under the curves was calculated by receiver operating characteristic (ROC) regression analysis. Results: The detumescence rate was 71.4% after the intervention. Compared to the control group, priapic SCA patients showed significantly higher PLT (p = 0.011), MPV (p = 0.002), PDW (p = 0.032), PCT values (p = 0.022), and TLC (p = 0.027). Higher MPV, PDW, and PCT values were observed in unsuccessful detumescence patients compared to the resolution group (p < 0.05). Statistically significant cutoff values for persistent priapism were measured by ROC as PLT: ⩾ 254x103/μL; MPV: ⩾ 13.2 fL; PDW: ⩾ 15.6 fL; PCT: ⩾ 24%; and TLC ≥ 8.5x103/L. Priapism duration of ≤ 17.9 hours was significantly related to detumescence rate (p = 0.000). Multivariable logistic regression analysis showed that priapism duration and higher MPV are prognostic parameters for detumescence in SCA. Conclusions: The higher MPV and duration of priapism can be used as parameters for evaluating detumescence outcomes in steady-state SCA with acute IP.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL. New insights into the pathophysiology of sickle cell disease associated priapism. J Sex Med. 2012; 9:79. DOI: https://doi.org/10.1111/j.1743-6109.2011.02288.x
Claudino MA, Fertrin KY. Sickling cells, cyclic nucleotides, and protein kinases: the pathophysiology of urogenital disorders in sickle cell anemia. Anemia. 2012; 2012:1-13. DOI: https://doi.org/10.1155/2012/723520
Adeyoju AB, Olujohungbe AB, Morris J, et al. Priapism in sickle cell disease; incidence, risk factors and complications-an international multicenter study. BJU Int. 2002; 90:898. DOI: https://doi.org/10.1046/j.1464-410X.2002.03022.x
Broderick GA, Kadioglu A, Bivalacqua TJ, et al. Priapism: Pathogenesis, epidemiology, and management. J Sex Med. 2010; 7:476. DOI: https://doi.org/10.1111/j.1743-6109.2009.01625.x
Berger R, Billups K, Brock G, et al. Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. Int J Impotence Res. 2001; 13(Suppl 5):S39. DOI: https://doi.org/10.1038/sj.ijir.3900777
von Stempel C, Zacharakis E, Allen C, et al. Mean velocity and peak systolic velocity can help determine ischaemic and nonischaemic priapism. Clin Radiol. 2017; 72:611. DOI: https://doi.org/10.1016/j.crad.2017.02.021
Ciftci H, Yeni E, Demir M, et al. the mean platelet volume be a risk factor for vasculogenic erectile dysfunction? World J Mens Health. 2013; 31:215. DOI: https://doi.org/10.5534/wjmh.2013.31.3.215
Madu AJ, Ubesie A, Ocheni S, et al. Priapism in homozygous sickle cell patients: important clinical and laboratory associations. Med Princ Pract. 2014; 23:259. DOI: https://doi.org/10.1159/000360608
Sönmez MG, Kara C, Karaibrahimoglu A, et al. Ischemic priapism: Can eosinophil count and platelet functions be positive predictive factors in etiopathogenesis. Can Urol Assoc J. 2017; 11:E297. DOI: https://doi.org/10.5489/cuaj.4263
Ufuk Y, Hasan Y, Murat U, et al. Does platelet activity play a role in the pathogenesis of idiopathic ischemic priapism? Int Braz J Urol. 2016; 42:118. DOI: https://doi.org/10.1590/S1677-5538.IBJU.2015.0126
Alkindi S, Almufargi SS, Pathare A. Clinical and laboratory parameters, risk factors predisposing to the development of priapism in sickle cell patients. Exp Biol Med. 2020; 245:79. DOI: https://doi.org/10.1177/1535370219892846
Ballas SK, Lieff S, Benjamin LJ, et al. Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol. 2010; 85:6. DOI: https://doi.org/10.1002/ajh.21550
Cita KC, Brureau L, Lemonne N, et al. Men with sickle cell anemia and priapism exhibit increased hemolytic rate, decreased red blood cell deformability and increased red blood cell aggregate strength. PLoS One. 2016; 11:e0154866. DOI: https://doi.org/10.1371/journal.pone.0154866
Salonia A, Eardley I, Giıliano F, et al. European Association of Urology guidelines on priapism. Eur Urol. 2014; 65:480. DOI: https://doi.org/10.1016/j.eururo.2013.11.008
Burnett AL, Sharlip ID. Standard operating procedures for priapism. J Sex Med. 2013; 10:180. DOI: https://doi.org/10.1111/j.1743-6109.2012.02707.x
Lancé MD, van Oerle R, Henskens YMC, Marcus MA. Do we need time adjusted mean platelet volume measurements? Lab. Hematol. 2010; 16:28. DOI: https://doi.org/10.1532/LH96.10011
Ghanem MA, Adawi EA, Hakami NA, et al. The predictive value of the platelet volume parameters in evaluation of varicocelectomy outcome in infertile patients. Andrologia 2020; 52:e13574. DOI: https://doi.org/10.1111/and.13574
Adawi EA, Ghanem MA, Ghanem AM, et al. High platelet distribution width can independently predict testicular survival in testicular torsion among steady state sickle cell anemia patients. World Jnl Ped Surgery. 2022; 5:e000358. DOI: https://doi.org/10.1136/wjps-2021-000358
Mutlu H, Artis T, Erden A, Akca Z. Alteration in mean platelet volume and platelet crit values in patients with cancer that developed thrombosis. Clin Appl Thromb Hemost. 2013; 19:331. DOI: https://doi.org/10.1177/1076029611433644
Chu SG, Becker RC, Berger PB, et al. Mean platelet volume as a predictor of cardiovascular risk: A systematic review and metaanalysis. J Thromb Haemost. 2010; 8:148. DOI: https://doi.org/10.1111/j.1538-7836.2009.03584.x
Ridgley J, Raison N, Sheikh MI, et al. Ischaemic priapism: A clinical review. J Urol. 2017; 43:1. DOI: https://doi.org/10.5152/tud.2017.59458
Champion HC, Bivalacqua T, Takimoto E, et al. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci USA. 2005; 102:1661. DOI: https://doi.org/10.1073/pnas.0407183102
Braekkan SK, Mathiesen EB, Njølstad I, et al. Mean platelet volume is a risk factor for venous thromboembolism: the Tromsø Study, Tromsø, Norway. J Thromb Haemost. 2010; 8:157. DOI: https://doi.org/10.1111/j.1538-7836.2009.03498.x
Wang JJ, Wang YL, Ge XX, et al. Prognostic values of plateletassociated indicators in resectable lung cancers. Technol Cancer Res Treat. 2019; 18:1533033819837261. DOI: https://doi.org/10.1177/1533033819837261
Makis AC, Hatzimichael EC, Bourantas KL. The role of cytokines in sickle cell disease. Ann Hematol. 2000; 79:407. DOI: https://doi.org/10.1007/s002770000173
Ahmed SG, Ibrahim UA, Hassan AW. Hematological parameters in sick cell anemia patients with and without priapism. Ann. Saudi Med. 2006; 26:439. DOI: https://doi.org/10.5144/0256-4947.2006.439
Conran N, Fattori A, Saad STO, Costa FF. Increased levels of soluble ICAM-1 in the plasma of sickle cell patients are reversed by hydroxyurea. Am J Hematol. 2004; 76:343. DOI: https://doi.org/10.1002/ajh.20129
Zacharakis E, Raheem AA, Freeman A, et al. The efficacy of the t-shunt procedure and intracavernous tunneling (snake maneuver) for refractory ischemic priapism. J Urol. 2014; 191:164. DOI: https://doi.org/10.1016/j.juro.2013.07.034
Ortac M, Cevik G, Akdere H, et al. Anatomic and functional outcome following distal shunt and tunneling for treatment ischemic priapism: A single-center experience. J Sex Med. 2019; 16:1290. DOI: https://doi.org/10.1016/j.jsxm.2019.05.011
Upadhyay J, Shekarriz B, Dhabuwala CB. Penile implant for intractable priapism associated with sickle cell disease. Urology. 1998; 5:638. DOI: https://doi.org/10.1016/S0090-4295(97)00704-8

How to Cite

Adawi, E. A., & Ghanem, M. A. (2022). Platelet volume parameters as a tool in the evaluation of acute ischemic priapism in patients with sickle cell anemia. Archivio Italiano Di Urologia E Andrologia, 94(2), 217–221. https://doi.org/10.4081/aiua.2022.2.217

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.